Rani Therapeutics - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi RANI
Rani Therapeutics (RANI) is scaling B2B licensing of its robotic capsules to achieve global market capture. The current EBITDA value confirms this trend, stabilizing at 0.00. Growth is driven by alliances with industry behemoths and the replacement of injections for diabetes treatment. Meanwhile, the US-based localization of development and the humanitarian status of medicine fully shield the company's patents from geopolitical risks.
Ringkesan rincian data analitis Rani Therapeutics Holdings, Inc. (RANI)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Rani Therapeutics|RANI - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Rani Therapeutics Holdings|RANI - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Rani Therapeutics|RANI - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Rani Therapeutics|Koefisien jangkoan perantara ranitherapeutics.com
- statistik bathi lan rasio pasar:
RANI - Penghasilan resik|Penghasilan resik sing dikarepake Rani Therapeutics|RANI - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Rani Therapeutics Holdings|RANI - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Rani Therapeutics|RANI - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Rani Therapeutics|RANI - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan ranitherapeutics.com|RANI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Rani Therapeutics
Ringkesan analitik perusahaan:RANI (Rani Therapeutics)
For Rani Therapeutics, which is scaling partnerships for the oral delivery of biologics, analyzing the absolute cash result of operations allows for an assessment of the real monetization efficiency of the RaniPill platform. This indicator measures the actual volume of operating cash flow before depreciation, alerting the investor to hidden liquidity contraction and capital erosion risks even before the publication of official financial statements.
Pesaing Rani Therapeutics (RANI)
Haleon Corp (HLN) - Bathi sadurunge bunga, pajak, lan amortisasi|KVUE: Bathi operasional sadurunge ngurangi amortisasi|veronapharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MENS: Bathi operasional EBITDA|Ligand Pharmaceuticals Incorporated - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|AMRX (Amneal Pharmaceuticals Inc) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Perrigo Corp PRGO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Alvotech (ALVO)|LQDA (liquidia.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Galapagos GLPG|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ANIP|MannKind Corp. - Bathi operasional EBITDA|AMPH - Bathi operasional EBITDA|Pacira BioSciences (PCRX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi SPRY|TBPH (Theravance Biopharma, Inc.) - Bathi operasional EBITDA|Aquestive Therapeutics Inc (AQST) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi SCPH (scPharmaceuticals Inc.)|TECX (tectonictx.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Tonix Pharmaceuticals - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi SXTC (SXT Pharmaceuticals)|Eupraxia Pharma - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi BHST (BioHarvest Sciences, Inc.)|EXOZ: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Oramed Pharmaceuticals Inc. (ORMP)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Entera Bio Ltd|HYFT: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ABVC|Bathi operasional EBITDA Cumberland Pharmaceuticals Inc (CPIX)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Quantum BioPharma Limited QNTM|FGEN (FibroGen Corporation) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Telomir Pharmaceuticals - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Synergy CHC Corp|RLYB (rallybio.com) - Bathi operasional sadurunge ngurangi amortisasi|Lexaria Bioscience Corp. (LEXX) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi PULM|PTHL (Pheton) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi operasional EBITDA APM|Pendapatan operasional sadurunge ngurangi amortisasi lyratherapeutics.com|Bathi operasional EBITDA IBO (Impact BioMedical)|TNFA - Bathi operasional sadurunge ngurangi amortisasi|YCBD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi PainReform Corp PRFX|altamiratherapeutics.com (CYTO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|lipella.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|OPTN (OptiNose) - Bathi operasional EBITDA|Bathi operasional EBITDA Pieris Pharmaceuticals Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Procaps Group SA (PROC)|Petros Pharma - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA QLI (Qilian International)|Pendapatan operasional sadurunge ngurangi amortisasi acelyrin.com (SLRN)|TFFP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi
